In the tumor microenvironment, HCC patients with low PRDX1 expression had more significant infiltration levels of M0 macrophages, M1 macrophages, CD4+ Th1 cells, CD4+ Th2 cells, myeloid dendritic cells, monocytes, and lymphoid progenitor cells. This evidence concerns the gene PRDX1 and neoplasm.